JP Stock MarketDetailed Quotes

331A Medix

Watchlist
  • 547
  • -11-1.97%
20min DelayMarket Closed May 2 15:30 JST
4.42BMarket Cap8.43P/E (Static)

Medix Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(FY)Mar 31, 2023
Total revenue
-2.18%4.18B
4.27B
Cost of revenue
-23.95%442.06M
581.28M
Gross profit
1.25%3.74B
3.69B
Operating expense
0.99%2.94B
2.91B
Operating profit
2.19%801.63M
784.42M
Net non-operating interest income (expenses)
2.79%-3.41M
-3.51M
Non-operating interest income
-56.72%325K
--751K
Non-operating interest expense
-12.30%3.74M
--4.26M
Net investment income
-101.48%-359K
24.18M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
0
-9.69M
Income from associates and other participating interests
Special income (charges)
-120.40%-16.9M
-7.67M
Less:Impairment of capital assets
257.31%1.2M
--335K
Less:Other special charges
114.15%15.7M
--7.33M
Other non-operating income (expenses)
104.48%6.74M
-150.59M
Income before tax
23.63%787.7M
637.14M
Income tax
26.86%298.51M
235.31M
Net income
21.74%489.2M
401.83M
Net income continuous operations
21.74%489.2M
--401.83M
Noncontrolling interests
Net income attributable to the company
21.74%489.2M
401.83M
Preferred stock dividends
Other under preferred stock dividend
0
0
Net income attributable to common stockholders
21.74%489.2M
401.83M
Gross dividend payment
Basic earnings per share
22.33%64.8486
53.0123
Diluted earnings per share
22.33%64.8486
53.0123
Dividend per share
Currency Unit
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
(FY)Mar 31, 2024(FY)Mar 31, 2023
Total revenue -2.18%4.18B4.27B
Cost of revenue -23.95%442.06M581.28M
Gross profit 1.25%3.74B3.69B
Operating expense 0.99%2.94B2.91B
Operating profit 2.19%801.63M784.42M
Net non-operating interest income (expenses) 2.79%-3.41M-3.51M
Non-operating interest income -56.72%325K--751K
Non-operating interest expense -12.30%3.74M--4.26M
Net investment income -101.48%-359K24.18M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets 0-9.69M
Income from associates and other participating interests
Special income (charges) -120.40%-16.9M-7.67M
Less:Impairment of capital assets 257.31%1.2M--335K
Less:Other special charges 114.15%15.7M--7.33M
Other non-operating income (expenses) 104.48%6.74M-150.59M
Income before tax 23.63%787.7M637.14M
Income tax 26.86%298.51M235.31M
Net income 21.74%489.2M401.83M
Net income continuous operations 21.74%489.2M--401.83M
Noncontrolling interests
Net income attributable to the company 21.74%489.2M401.83M
Preferred stock dividends
Other under preferred stock dividend 00
Net income attributable to common stockholders 21.74%489.2M401.83M
Gross dividend payment
Basic earnings per share 22.33%64.848653.0123
Diluted earnings per share 22.33%64.848653.0123
Dividend per share
Currency Unit JPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAP